Your browser doesn't support javascript.
loading
Altered fronto-amygdalar functional connectivity predicts response to cognitive behavioral therapy in pediatric obsessive-compulsive disorder.
Cyr, Marilyn; Pagliaccio, David; Yanes-Lukin, Paula; Goldberg, Pablo; Fontaine, Martine; Rynn, Moira A; Marsh, Rachel.
Afiliação
  • Cyr M; Division of Child and Adolescent Psychiatry, New York State Psychiatric Institute, New York, New York, USA.
  • Pagliaccio D; Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
  • Yanes-Lukin P; Division of Child and Adolescent Psychiatry, New York State Psychiatric Institute, New York, New York, USA.
  • Goldberg P; Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
  • Fontaine M; Division of Child and Adolescent Psychiatry, New York State Psychiatric Institute, New York, New York, USA.
  • Rynn MA; Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
  • Marsh R; Division of Child and Adolescent Psychiatry, New York State Psychiatric Institute, New York, New York, USA.
Depress Anxiety ; 38(8): 836-845, 2021 08.
Article em En | MEDLINE | ID: mdl-34157177
BACKGROUND: Based on findings from adults with obsessive-compulsive disorder (OCD), this study examined alterations in resting-state functional connectivity (rs-fc) between the basolateral amygdala (BLA) and the ventromedial prefrontal cortex (vmPFC) in children and adolescents with OCD. We also assessed whether such BLA-vmPFC connectivity changed with or predicted response to exposure and response prevention (E/RP), the first-line treatment for pediatric OCD, given the involvement of these regions in fear processing, regulation, and extinction learning-a probable mechanism of action of E/RP. METHODS: Resting state functional magnetic resonance imaging scans were acquired from 25 unmedicated, treatment-naïve pediatric patients with OCD (12.8 ± 2.9 years) and 23 age- and sex-matched healthy controls (HCs; 11.0 ± 3.3 years). Patients completed a 12-16-week E/RP intervention for OCD. Participants were rescanned after the 12-16-week period. ANCOVAs tested group differences in baseline rs-fc. Cross-lagged panel models examined relationships between BLA-vmPFC rs-fc and OCD symptoms pre- and posttreatment. All tests were adjusted for participants' age, sex, and head motion. RESULTS: Right BLA-vmPFC rs-fc was significantly reduced (more negative) in patients with OCD relative to HCs at baseline, and increased following treatment. In patients, more positive (less negative) right BLA-vmPFC rs-fc pretreatment predicted greater OCD symptoms reduction posttreatment. Changes in BLA-vmPFC rs-fc was unassociated with change in OCD symptoms pre- to posttreatment. CONCLUSIONS: These results provide further evidence of the BLA-vmPFC pathway as a potential target for novel treatments or prevention strategies aimed at facilitating adaptive learning and fear extinction in children with OCD or subclinical OCD symptoms.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Cognitivo-Comportamental / Transtorno Obsessivo-Compulsivo Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Cognitivo-Comportamental / Transtorno Obsessivo-Compulsivo Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article